S&P 500   3,257.90 (+0.35%)
DOW   26,840.51 (+0.09%)
QQQ   268.66 (+1.23%)
AAPL   110.57 (+2.17%)
MSFT   206.36 (+1.56%)
FB   251.04 (+0.61%)
GOOGL   1,427.77 (+0.35%)
AMZN   3,048.00 (+0.93%)
TSLA   406.88 (+4.92%)
NVDA   505.05 (+2.25%)
BABA   267.54 (-0.81%)
CGC   13.94 (-2.31%)
GE   6.05 (-0.17%)
MU   48.48 (-2.00%)
AMD   76.67 (+1.12%)
T   27.82 (-0.78%)
F   6.55 (-1.65%)
ACB   5.00 (-3.85%)
GILD   62.01 (-0.39%)
NFLX   477.38 (+0.91%)
DIS   122.69 (+0.16%)
BAC   23.22 (-0.51%)
BA   151.22 (+3.54%)
S&P 500   3,257.90 (+0.35%)
DOW   26,840.51 (+0.09%)
QQQ   268.66 (+1.23%)
AAPL   110.57 (+2.17%)
MSFT   206.36 (+1.56%)
FB   251.04 (+0.61%)
GOOGL   1,427.77 (+0.35%)
AMZN   3,048.00 (+0.93%)
TSLA   406.88 (+4.92%)
NVDA   505.05 (+2.25%)
BABA   267.54 (-0.81%)
CGC   13.94 (-2.31%)
GE   6.05 (-0.17%)
MU   48.48 (-2.00%)
AMD   76.67 (+1.12%)
T   27.82 (-0.78%)
F   6.55 (-1.65%)
ACB   5.00 (-3.85%)
GILD   62.01 (-0.39%)
NFLX   477.38 (+0.91%)
DIS   122.69 (+0.16%)
BAC   23.22 (-0.51%)
BA   151.22 (+3.54%)
S&P 500   3,257.90 (+0.35%)
DOW   26,840.51 (+0.09%)
QQQ   268.66 (+1.23%)
AAPL   110.57 (+2.17%)
MSFT   206.36 (+1.56%)
FB   251.04 (+0.61%)
GOOGL   1,427.77 (+0.35%)
AMZN   3,048.00 (+0.93%)
TSLA   406.88 (+4.92%)
NVDA   505.05 (+2.25%)
BABA   267.54 (-0.81%)
CGC   13.94 (-2.31%)
GE   6.05 (-0.17%)
MU   48.48 (-2.00%)
AMD   76.67 (+1.12%)
T   27.82 (-0.78%)
F   6.55 (-1.65%)
ACB   5.00 (-3.85%)
GILD   62.01 (-0.39%)
NFLX   477.38 (+0.91%)
DIS   122.69 (+0.16%)
BAC   23.22 (-0.51%)
BA   151.22 (+3.54%)
S&P 500   3,257.90 (+0.35%)
DOW   26,840.51 (+0.09%)
QQQ   268.66 (+1.23%)
AAPL   110.57 (+2.17%)
MSFT   206.36 (+1.56%)
FB   251.04 (+0.61%)
GOOGL   1,427.77 (+0.35%)
AMZN   3,048.00 (+0.93%)
TSLA   406.88 (+4.92%)
NVDA   505.05 (+2.25%)
BABA   267.54 (-0.81%)
CGC   13.94 (-2.31%)
GE   6.05 (-0.17%)
MU   48.48 (-2.00%)
AMD   76.67 (+1.12%)
T   27.82 (-0.78%)
F   6.55 (-1.65%)
ACB   5.00 (-3.85%)
GILD   62.01 (-0.39%)
NFLX   477.38 (+0.91%)
DIS   122.69 (+0.16%)
BAC   23.22 (-0.51%)
BA   151.22 (+3.54%)
Log in
NASDAQ:HRMY

Harmony Biosciences Stock Forecast, Price & News

$33.58
+1.11 (+3.42 %)
(As of 09/25/2020 11:19 AM ET)
Add
Compare
Today's Range
$32.49
Now: $33.58
$33.75
50-Day Range N/A
52-Week Range
$30.11
Now: $33.58
$47.37
Volume2,036 shs
Average Volume257,519 shs
Market Capitalization$2.14 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.27 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HRMY
CUSIPN/A
CIKN/A
Phone484 539 9800

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees150
Market Cap$2.14 billion
Next Earnings DateN/A
OptionableNot Optionable
$33.58
+1.11 (+3.42 %)
(As of 09/25/2020 11:19 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HRMY News and Ratings via Email

Sign-up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Harmony Biosciences (NASDAQ:HRMY) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Harmony Biosciences?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Harmony Biosciences in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Harmony Biosciences
.

What price target have analysts set for HRMY?

3 brokerages have issued 12-month target prices for Harmony Biosciences' stock. Their forecasts range from $43.00 to $61.00. On average, they anticipate Harmony Biosciences' share price to reach $51.67 in the next twelve months. This suggests a possible upside of 53.9% from the stock's current price.
View analysts' price targets for Harmony Biosciences
.

Who are some of Harmony Biosciences' key competitors?

What other stocks do shareholders of Harmony Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Harmony Biosciences investors own include Advance Auto Parts (AAP), Advanced Micro Devices (AMD), Berry Global Group (BERY), Bunge (BG), Carrier Global (CARR), Commercial Metals (CMC), Canadian Solar (CSIQ), Deere & Company (DE), Eastman Chemical (EMN) and Edwards Lifesciences (EW).

Who are Harmony Biosciences' key executives?

Harmony Biosciences' management team includes the following people:
  • Mr. Jeffrey S. Aronin, Founder & Non-Exec. Chairman (Age 52)
  • Mr. John Charles Jacobs M.B.A., Pres, CEO & Director (Age 53)
  • Ms. Susan L. Drexler C.P.A., M.B.A., Chief Financial Officer (Age 51)
  • Mr. David Bradshaw, Head of Technical Operations
  • Ms. Sharon Goldbach, Head of Facilities Operations & Exec. Admin.

When did Harmony Biosciences IPO?

(HRMY) raised $101 million in an initial public offering on Wednesday, August 19th 2020. The company issued 4,700,000 shares at $20.00-$23.00 per share. Goldman Sachs, Jefferies and Piper Sandler served as the underwriters for the IPO.

What is Harmony Biosciences' stock symbol?

Harmony Biosciences trades on the NASDAQ under the ticker symbol "HRMY."

How do I buy shares of Harmony Biosciences?

Shares of HRMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Harmony Biosciences' stock price today?

One share of HRMY stock can currently be purchased for approximately $33.58.

How big of a company is Harmony Biosciences?

Harmony Biosciences has a market capitalization of $2.14 billion. Harmony Biosciences employs 150 workers across the globe.

What is Harmony Biosciences' official website?

The official website for Harmony Biosciences is www.harmonybiosciences.com.

How can I contact Harmony Biosciences?

Harmony Biosciences' mailing address is 630 W GERMANTOWN PIKE SUITE 215, PLYMOUTH MEETING PA, 19462. The company can be reached via phone at 484 539 9800 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.